Warm autoimmune hemolytic anemia: A clinical model to study mechanisms of immunoregulation

Transfusion Medicine and Hemotherapy

Volumn 33, Issue 2, 2006, Pages 135-143

  Stahl, Dorothea ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Immune complex; Immunoregulation; Natural autoreactivity; Self tolerance; Warm autoimmune hemolytic anemia

Indexed keywords

ANTIGEN; AUTOANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; BIOLOGY; CELLULAR IMMUNITY; CONFERENCE PAPER; GENETIC SELECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE COMPLEX DISEASE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULE; NONHUMAN;

EID: 33645671429     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091108     Document Type: Conference Paper

References (146)

1. Ehrlich P, Morgenroth J: Über Hämolysine: Dritte Mitteilung. Berl. Klin Wochenschr 1900;37:453-458 and 681-687.
2. Silverstein AM: The side-chain theory of antibody formation, in Silverstein AM (ed): Paul Ehrlich's receptor immunology: The magnificent obsession. San Diego, Academic Press, 2002, pp 77-94.
3. Silverstein AM: Immune hemolysis: Bordet challenges Ehrlich, in Silverstein AM (ed): Paul Ehrlich's receptor immunology: The magnificent obsession. San Diego, Academic Press, 2002, pp 95-122.
4. Landsteiner K: Über Agglutinationserscheinungen normalen menschlichen Blutes. Wien Klin Wochenschr 1901;14:956-958.
5. Billingham RE, Brent L, Medawar PB: Activity acquired tolerance of foreign cells. Nature 1953;172 (4379):603-606.
6. Burnet FM: The clonal selection theory of antibody formation. London, Cambridge University Press, 1959.
7. Burnet FM: Immunological recognition of self. Science 1961;133:307-311.
8. Nossal GJ, Pike BL: Evidence for the clonal abortion theory of B-lymphocyte tolerance. J Exp Med 1975;141(4):904-917.
9. Kappler J, Roehm N, Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-280.
10. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, et al: Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334(6184):676-682.
11. Tiegs SL, Russell DM, Nemazee D: Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993;177(4):1009-1020.
12. Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI, Akkaraju S, Rathmell JC, Pogue SL, Shokat KP: Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 1995;59:279-368.
13. Goodnow CC: Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A 1996;93(6):2264-2271.
14. Stockinger B: T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv Immunol 1999;71:229-265.
15. Walker LS, Abbas AK: The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002;2(1):11-19.
16. Rice JS, Newman J, Wang C, Michael DJ, Diamond B: Receptor editing in peripheral B cell tolerance. Proc Natl Acad Sci U S A 2005;102(5):1608-1613.
17. Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot EM, Goodnow CC, Carroll MC: A critical role for complement in maintenance of self-tolerance. Immunity 1998;9(5):721-731.
18. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155(3):1151-1164.
19. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001;182:18-32.
20. Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2(6):389-400.
21. Takahashi T, Sakaguchi S: Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologie self-tolerance and preventing autoimmune disease. Curr Mol Med 2003;3(8):693-706.
22. Nomura T, Sakaguchi S: Naturally arising CD25+ CD4+ regulatory T cells in tumor immunity. Curr Top Microbiol Immunol 2005;293:287-302.
23. You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L: Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc Natl Acad Sci U S A 2004;101(suppl 2):14580-14585.
24. Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6 (4):345-352.
25. Ludewig B, Junt T, Hengartner H, Zinkernagel RM: Dendritic cells in autoimmune diseases. Curr Opin Immunol 2001;13(6):657-662.
26. Ludewig B, Krebs P, Junt T, Bocharov G: Dendritic cell homeostasis in the regulation of self-reactivity. Curr Pharm Des 2003;9(3):221-231.
27. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P Antonia SJ, Burgess R, Slingluff CL, Jr., Mellor AL: Potential regulatory function of human dendritic cells expressing indoleamine 2.3-dioxygenase. Science 2002;297(5588):1867-1870.
28. Mellor AL, Baban B, Chandler P, Marshall B, Jhaver K, Hansen A, Koni PA, Iwashima M, Munn DH: Cutting edge: induced indoleamine 2.3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 2003;171(4):1652-1655.
29. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G: Inhibition of allogeneic T cell proliferation by indoleamine 2.3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002;196(4):447-457.
30. Terness P, Chuang JJ, Bauer T, Jiga L, Opelz G: Regulation of human auto- and alloreactive T cells by indoleamine 2.3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO? Blood 2005;105(6):2480-2486.
31. Munn DH, Mellor AL, Rossi M, Young JW: Dendritic cells have the option to express IDO-mediated suppression or not. Blood 2005;105(6):2618.
32. Munn DH, Mellor AL: Macrophages and the regulation of self-reactive T cells. Curr Pharm Des 2003;9(3):257-264.
33. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005;436 (7051):709-713.
34. Terness P, Opelz G: Regulation of antibody response by an IgG-anti-Ig autoantibody occurring during alloimmunization. I. A few IgG molecules inactivate one B cell. Transplantation 1992;54(1):88-91.
35. Terness P, Marx U, Sandilands G, Roelcke D, Welschof M, Opelz G: Suppression of anti-erythrocyte autoantibody-producing B cells by a physiological IgG-anti-F(ab′)2 antibody and escape from suppression by tumour transformation; a model relevant for the pathogenesis of autoimmune haemolytic anaemia. Clin Exp Immunol 1993;93(2):253-258.
36. Terness P, Kohl I, Hubener G, Battistutta R, Moroder L, Welschof M, Dufter C, Finger M, Hain C, Jung M, et al: The natural human IgG anti-F(ab′)2 antibody recognizes a conformational IgG1 hinge epitope. J Immunol 1995;154(12):6446-6452.
37. Terness P, Kirschfink M, Navolan D, Dufter C, Kohl I, Opelz G, Roelcke D: Striking inverse correlation between IgG anti-F(ab′)2 and autoantibody production in patients with cold agglutination. Blood 1995;85(2):548-551.
38. Terness P, Navolan D, Moroder L, Siedler F, Weyher E, Kohl I, Dufter C, Welschof M, Drugarin D, Schneider F, Opelz G: A natural IgA-anti-F(ab′) 2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope. J Immunol 1996;157 (9):4251-4257.
39. Welschof M, Terness P, Kipriyanov SM, Stanescu D, Breitling F, Dorsam H, Dubel S, Little M, Opelz G: The antigen-binding domain of a human IgG-anti-F(ab′)2 autoantibody. Proc Natl Acad Sci U S A 1997;94(5):1902-1907.
40. Welschof M, Reineke U, Kleist C, Kipriyanov S, Little M, Volkmer-Engert R, Schneider-Mergener J, Opelz G, Terness P: The antigen binding domain of non-idiotypic human anti-F(ab′)2 autoantibodies: study of their interaction with IgG hinge region epitopes. Hum Immunol 1999;60(4):282-290.
41. Kazatchkine MD, Kaveri SV: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345(10):747-755.
42. De Grandmont MJ, Racine C, Roy A, Lemieux R, Neron S: Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG. Blood 2003;101(8):3065-3073.
43. Ravetch JV, Lanier LL: Immune inhibitory receptors. Science 2000;290(5489):84-89.
44. Samuelsson A, Towers TL, Ravetch JV: Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001;291(5503):484-486.
45. Fossati-Jimack L, Ioan-Facsinay A, Reininger L, Chicheportiche Y, Watanabe N, Saito T, Hofhuis FM, Gessner JE, Schiller C, Schmidt RE, Honjo T, Verbeek JS, Izui S: Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J Exp Med 2000;191(8):1293-1302.
46. Alarcon-Segovia D, Ruiz-Arguelles A: Antibody penetration into living cells. A new mechanism of immunologically mediated damage. Rev Invest Clin 1979;31(2):111-120.
47. Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Alarcon-Segovia D: Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications. Curr Pharm Des 2003;9(23):1881-1887.
48. Besredka M: Ann Inst Pasteur (Paris) 1901;15:785.
49. Metalnikoff S: Ann Inst Pasteur (Paris) 1900;9:577.
50. Jerne NK: The immune system: a web of V-domains. Harvey Lect 1974;70 Series:93-110.
51. Jerne NK: Towards a network theory of the immune system. Ann Immunol (Paris) 1974;125C (1-2):373-389.
52. Lefkovits I (ed): A Portrait of the Immune System. Scientific Publications of N K Jerne. Singapore, World Scientific Publishing, 1996.
53. Varela FJ, Coutinho A: Second generation immune networks. Immunol Today 1991;12(5):159-166.
54. Coutinho A: Simple developmental programs of gene expression and cellular composition of lymphoid organs at the origin of natural tolerance. Res Immunol 1995;146(4-5):321-332.
55. Coutinho A: Will the idiotypic network help to solve natural tolerance? Trends Immunol 2003;24 (2):53-54.
56. Cohen IR: The cognitive paradigm and the immunological homunculus. Immunol Today 1992;13 (12):490-494.
57. Cohen IR: The cognitive principle challenges clonal selection. Immunol Today 1992;13(11):441-444.
58. Cohen IR: Discrimination and dialogue in the immune system. Semin Immunol 2000;12(3):215-219; discussion 257-344.
59. Cohen IR: Antigenic mimicry, clonal selection and autoimmunity. J Autoimmun 2001;16(3):337-340.
60. Quintana FJ, Cohen IR: The natural autoantibody repertoire and autoimmune disease. Biomed Pharmacother 2004;58(5):276-281.
61. Filion MC, Bradley AJ, Devine DV, Decary F, Chartrand P: Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. Eur J Immunol 1995;25(11):3123-3127.
62. Filion MC, Proulx C, Bradley AJ, Devine DV, Sekaly RP, Decary F, Chartrand P: Presence in peripheral blood of healthy individuals of autoreactive T cells to a membrane antigen present on bone marrow-derived cells. Blood 1996;88(6):2144-2150.
63. Rubin RL, Kretz-Rommel A: Linkage of immune self-tolerance with the positive selection of T cells. Crit Rev Immunol 1999;19(3):199-218.
64. Kretz-Rommel A, Rubin RL: Disruption of positive selection of thymocytes causes autoimmunity. Nat Med 2000;6(3):298-305.
65. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M: Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 1999;5 (1):49-55.
66. Schwartz M, Cohen IR: Autoimmunity can benefit self-maintenance. Immunol Today 2000;21(6):265-268.
67. Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, Silver J, Hardy RR: Positive selection of natural autoreactive B cells. Science 1999;285(5424):113-116.
68. Koenig-Marrony S, Soulas P, Julien S, Knapp AM, Garaud JC, Martin T, Pasquali JL: Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory. J Immunol 2001;166(3):1463- 1470.
69. Julien S, Soulas P, Garaud JC, Martin T, Pasquali JL: B cell positive selection by soluble self-antigen. J Immunol 2002;169(8):4198-4204.
70. Hayakawa K, Asano M, Shinton SA, Gui M, Wen LJ, Dashoff J, Hardy RR: Positive selection of antithy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J Exp Med 2003;197 (1):87-99.
71. Coutinho A, Kazatchkine MD, Avrameas S: Natural autoantibodies. Curr Opin Immunol 1995;7(6):812-818.
72. Lacroix-Desmazes S, Kaveri SV, Mouthon L, Ayouba A, Malanchere E, Coutinho A, Kazatchkine MD: Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 1998;216(1-2):117-137.
73. Bendelac A, Bonneville M, Kearney JF: Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001;1(3):177-186.
74. Moalem G, Yoles E, Leibowitz-Amit R, Muller-Gilor S, Mor F, Cohen IR, Schwarte M: Autoimmune T cells retard the loss of function in injured rat optic nerves. J Neuroimmunol 2000;106(1-2):189-197.
75. Mizrahi T, Hauben E, Schwartz M: The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis. J Immunol 2002;169(10):5971-5977.
76. Wang H, Shlomchik MJ: Maternal Ig mediates neonatal tolerance in rheumatoid factor transgenic mice but tolerance breaks down in adult mice. J Immunol 1998;160(5):2263-2271.
77. Manz RA, Arce S, Cassese G, Hauser AE, Hiepe F, Radbruch A: Humoral immunity and long-lived plasma cells. Curr Opin Immunol 2002;14(4):517-521.
78. Zouali M: B cell diversity and longevity in systemic autoimmunity. Mol Immunol 2002;38(12-13):895-901.
79. Sprent J, Surh CD: T cell memory. Annu Rev Immunol 2002;20:551-579.
80. Dorner T, Radbruch A: Selecting B cells and plasma cells to memory. J Exp Med 2005;201(4):497-499.
81. Manz RA, Hauser AE, Hiepe F, Radbruch A: Maintenance of serum antibody levels. Annu Rev Immunol 2005;23:367-386.
82. Avrameas S: Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 1991;12(5):154-159.
83. Nobrega A, Haury M, Grandien A, Malanchere E, Sundblad A, Coutinho A: Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological 'homunculus' of antibodies in normal serum. Eur J Immunol 1993;23(11):2851-2859.
84. Vasconcellos R, Nobrega A, Haury M, Viale AC, Coutinho A: Genetic control of natural antibody repertoires: I. IgH, MHC and TCR beta loci. Eur J Immunol 1998;28(3):1104-1115.
85. Fesel C, Coutinho A: Structured reactions of serum IgM repertoires to immunization are dependent on major histocompatibility complex genes. Scand J Immunol 1999;49(3):251-257.
86. Coutinho A: Germ-line selection ensures embryonic autoreactivity and a positive discrimination of self mediated by supraclonal mechanisms. Semin Immunol 2000;12(3):205-213, discussion 257-344.
87. Coutinno A, Haas W: In vivo models of dominant T-cell tolerance: where do we stand today? Trends Immunol 2001;22(7):350-351.
88. Anderson G, Hare KJ, Jenkinson EJ: Positive selection of thymocytes: the long and winding road. Immunol Today 1999;20(10):463-468.
89. Cohen IR, Young DB: Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991;12(4):105-110.
90. Mouthon L, Lacroix-Desmazes S, Stahl D, Kaveri SV, Coutinho A, Kazatchkine MD: Self-reactive antibody repertoires: the ' antibody homunculus'; in Talwar GP, Nath I, Ganguly NK, Rao KSV (eds): 10th International Congress of Immunology. Bologna, Monduzzi Editore, 1999, pp 729-734.
91. Stahl D, Lacroix-Desmazes S, Mouthon L, Kaveri SV, Kazatchkine MD: Analysis of human self-reactive antibody repertoires by quantitative immunoblotting. J Immunol Methods 2000;240(1-2):1-14.
92. Mouthon L, Nobrega A, Nicolas N, Kaveri SV, Barreau C, Coutinho A, Kazatchkine MD: Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci U S A 1995;92(9):3839-3843.
93. Mouthon L, Haury M, Lacroix-Desmazes S, Barreau C, Coutinho A, Kazatchkine MD: Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J Immunol 1995;154(11):5769-5778.
94. Mouthon L, Lacroix-Desmazes S, Nobrega A, Barreau C, Coutinho A, Kazatchkine MD: The self-reactive antibody repertoire of normal human serum IgM is acquired in early childhood and remains conserved throughout life. Scand J Immunol 1996;44(3)243-251.
95. Lacroix-Desmazes S, Mouthon L, Coutinho A, Kazatchkine MD: Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens. Eur J Immunol 1995;25(9):2598-2604.
96. Lacroix-Desmazes S, Mouthon L, Kaveri SV, Kazatchkine MD, Weksler ME: Stability of natural self-reactive antibody repertoires during aging. J Clin Immunol 1999;19(1):26-34.
97. Lacroix-Desmazes S, Resnick I, Stahl D, Mouthon L, Espanol T, Levy J, Kaveri SV, Notarangelo L, Eibl M, Fischer A, Ochs H, Kazatchkine MD: Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol 1999;162(9):5601-5608.
98. Stahl D, Lacroix-Desmazes S, Misra N, Karmochkine M, Kaveri SV, Costagliola D, Sibrowski W, Kazatchkine MD: Alterations of self-reactive antibody repertoires in HIV disease: An insight into the role of T cells in the selection of autoreactive B cells. Immunol Lett 2005;99(2):198-208.
99. Sundblad A, Marcos M, Huetz F, Freitas A, Heusser C, Portnoi D, Coutinho A: Normal serum immunoglobulins influence the numbers of bone marrow pre-B and B cells. Eur J Immunol 1991;21(5):1155-1161.
100. Baker N, Ehrenstein MR: Cutting Edge: Selection of B Lymphocyte Subsets Is Regulated by Natural IgM. J Immunol 2002;169(12):6686-6690.
101. Nielsen CH, Leslie RG, Jepsen BS, Kazatchkine MD, Kaveri SV, Eischer E: Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4(+) T cells in healthy individuals. Eur J Immunol 2001;31 (9):2660-2668.
102. Aktas O, Zipp F: Regulation of self-reactive T cells by human immunoglobulins- implications for multiple sclerosis therapy. Curr Pharm Des 2003;9 (3):245-256.
103. Cartron JP, Colin Y: Structural and functional diversity of blood group antigens. Transfus Clin Biol 2001;8(3):163-199.
104. Oldenburg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP: Role of CD47 as a marker of self on red blood cells. Science 2000;288 (5473):2051-2054.
105. Oldenburg PA: Role of CD47 in erythroid cells and in autoimmunity. Leuk Lymphoma 2004;45 (7):1319-1327.
106. Oldenborg PA, Gresham HD, Lindberg FP: CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med 2001;193(7):855-562.
107. Lutz HU, Flepp R, Stammler P, Baccala R: Red cell associated, naturally occurring anti-spectrin antibodies. Clin Exp Immunol 1987;67(3):674-676.
108. Lutz HU: Naturally occurring anti-band 3 antibodies. Transfus Med Rev 1992;6(3):201-211.
109. Spalter SH, Kaveri SV, Bonnin E, Mani JC, Cartron JP, Kazatchkine MD: Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens. Blood 1999;93(12):4418-4424.
110. Gehrs BC, Friedberg RC: Autoimmune hemolytic anemia. Am J Hematol 2002;69(4):258-271.
111. Engelfriet CP, Overbeeke MA, von dem Borne AE: Autoimmune hemolytic anemia. Semin Hematol 1992;29(1):3-12.
112. Garratty G: Autoimmune hemolytic anemia, in Garratty G (ed): Immunobiology of Transfusion Medicine. New York, Marcel Dekker, 1994, pp 493.
113. Meyer D, Schiller C, Westermann J, Izui S, Hazenbos WL, Verbeek JS, Schmidt RE, Gessner JE: FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood 1998;92(11):3997-4002.
114. Fossati-Jimack L, Reininger L, Chicheportiche Y, Clynes R, Ravetch JV, Honjo T, Izui S: High pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia. J Exp Med 1999;190(11):1689-1696.
115. Schiller C, Janssen-Graalfs I, Baumann U, Schwerter-Strumpf K, Izui S, Takai T, Schmidt RE, Gessner JE: Mouse FcgammaRII is a negative regulator of FcgammaRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis. Eur J Immunol 2000;30 (2):481-490.
116. Izui S, Fossati-Jimack L, da Silveira SA, Moll T: Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia. Springer Semin Immunopathol 2001;23(4):433-445.
117. Azeredo da Silveira S, Kikuchi S, Fossati-Jimack L, Moll T, Saito T, Verbeek JS, Botto M, Walport MJ, Carroll M, Izui S: Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity antierythrocyte autoantibody. J Exp Med 2002;195(6):665-672.
118. Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I, Izui S, Liu FT: Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 2003;112(3):389-397.
119. Barker RN, Casswell KM, Reid ME, Sokol RJ, Elson CJ: Identification of autoantigens in autoimmune haemolytic anaemia by a non-radioisotope immunoprecipitation method. Br J Haematol 1992;82(1):126-132.
120. Leddy JP, Falany JL, Kissel GE, Passador ST, Rosenfeld SI: Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies. J Clin Invest 1993;91(4):1672-1680.
121. Shen CR, Youssef AR, Devine A, Bowie L, Hall AM, Wraith DC, Elson CJ, Barker RN: Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia. Blood 2003;102(10):3800-386.
122. Issitt PD, Zellner DC, Rolih SD, Duckett JB: Autoantibodies mimicking alloantibodies. Transfusion 1977;17(6):531-538.
123. Garratty G: The significance of IgG on the red cell surface. Transfus Med Rev 1987;1(1):47-57.
124. Adib M, Ragimbeau J, Avrameas S, Ternynck T: IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol 1990;145(11):3807-3813.
125. Hurez V, Kaveri SV, Kazatchkine MD: Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur J Immunol 1993;23(4):783-789.
126. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J: Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 1998;160(10):4776-4787.
127. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J: Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A 2000;97(3):1184-1189.
128. Ehrenstein MR, Cook HT, Neuberger MS: Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 2000;191(7):1253-1258.
129. Hentati B, Payelle-Brogard B, Jouanne C, Avrameas S, Ternynck T: Natural autoantibodies are involved in the haemolytic anaemia of NZB mice. J Autoimmun 1994;7(4):425-439.
130. Stahl D, Lacroix-Desmazes S, Heudes D, Mouthon L, Kaveri SV, Kazatchkine MD: Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia. Blood 2000;95(1):328-335.
131. Stahl D, Lacroix-Desmazes S, Kaveri SV, Kazatchkine MD: Polyreactivity of disease-associated anti-RBC IgG autoantibodies of patients with warm autoimmune haemolytic anaemia and natural anti-RBC IgG autoantibodies of healthy individuals. Scand J Immunol 2000;52(2):190-199.
132. Stahl D, Sibrowski W: Warm autoimmune hemolytic anemia is an immune complex disease. J Autoimmun;2005;25(4):272-282.
133. Park YH, Miyama-Inaba M, Suzuki T, Masuda T, Yoshida Y, Uchino H: Immunological characterization of FcR gamma bearing and nonbearing B cells: functional modulation of immune complexes. Cell Immunol 1984;83(2):340-350.
134. Heyman B: Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol 2000;18:709-737.
135. Sakamoto N, Shibuya K, Shimizu Y, Yotsumoto K, Miyabayashi T, Sakano S, Tsuji T, Nakayama E, Nakauchi H, Shibuya A: A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur J Immunol 2001;31(5):1310-1316.
136. Heyman B: The immune complex: possible ways of regulating the antibody response. Immunol Today 1990;11(9):310-3.
137. Hamano Y, Arase H, Saisho H, Saito T: Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J Immunol 2000;164(12):6113-6119.
138. Kumpel BM, Elson CJ: Mechanism of anti-D-mediated immune suppression - a paradox awaiting resolution? Trends Immunol 2001;22(1):26-31.
139. Erdei A, Prechl J, Isaak A, Molnar E: Regulation of B-cell activation by complement receptors CD21 and CD35. Curr Pharm Des 2003;9(23):1849-60.
140. Heyman B: Feedback regulation by IgG antibodies. Immunol Lett 2003;88(2):157-61.
141. Kalergis AM: Modulation of T cell immunity by TCR/pMHC dwell time and activating/inhibitory receptor pairs on the antigen-presenting cell. Curr Pharm Des 2003;9(3):233-244.
142. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A: Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416(6881):603-7.
143. Haberman AM, William J, Euler C, Shlomchik MJ: Rheumatoid factors in health and disease: structure, function, induction and regulation, in Nemazee D (ed): B Cell Biology in Autoimmunity. Curr Dir Autoimmun. Basel, Karger, 2003, vol 6, pp 169-195.
144. Wang S, Yang T, Zhang J, Xiao S, Peng X: Analysis of Ig/Ig two-component-determined circulating immune complexes (TCIC) provide new insights into host immunity. Int Immunopharmacol 2003;3(10-11):1549-1555.
145. Roux KH, Strelets L, Michaelsen TE: Flexibility of human IgG subclasses. J Immunol 1997;159(7):3372-3382.
146. Roux KH, Strelets L, Brekke OH, Sandlie I, Michaelsen TE: Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry. J Immunol 1998;161(8):4083-4090.